150 related articles for article (PubMed ID: 7516330)
1. Internalization of fibroblast growth factor receptor is inhibited by a point mutation at tyrosine 766.
Sorokin A; Mohammadi M; Huang J; Schlessinger J
J Biol Chem; 1994 Jun; 269(25):17056-61. PubMed ID: 7516330
[TBL] [Abstract][Full Text] [Related]
2. Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis.
Mohammadi M; Dionne CA; Li W; Li N; Spivak T; Honegger AM; Jaye M; Schlessinger J
Nature; 1992 Aug; 358(6388):681-4. PubMed ID: 1379698
[TBL] [Abstract][Full Text] [Related]
3. Point mutation in the fibroblast growth factor receptor eliminates phosphatidylinositol hydrolysis without affecting neuronal differentiation of PC12 cells.
Spivak-Kroizman T; Mohammadi M; Hu P; Jaye M; Schlessinger J; Lax I
J Biol Chem; 1994 May; 269(20):14419-23. PubMed ID: 7514169
[TBL] [Abstract][Full Text] [Related]
4. Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+ flux but not mitogenesis.
Peters KG; Marie J; Wilson E; Ives HE; Escobedo J; Del Rosario M; Mirda D; Williams LT
Nature; 1992 Aug; 358(6388):678-81. PubMed ID: 1379697
[TBL] [Abstract][Full Text] [Related]
5. Characterization of [125I]acidic fibroblast growth factor binding to the cloned human fibroblast growth factor receptor, FGF-flg, on NIH 3T3 cell membranes: inhibitory effects of heparin, pertussis toxin and guanine nucleotides.
Jarvis MF; Gessner GW; Martin GE; Jaye M; Ravera MW; Dionne CA
J Pharmacol Exp Ther; 1992 Oct; 263(1):253-63. PubMed ID: 1383494
[TBL] [Abstract][Full Text] [Related]
6. Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships.
McKeehan WL; Kan M
Mol Reprod Dev; 1994 Sep; 39(1):69-81; discusison 81-2. PubMed ID: 7999363
[TBL] [Abstract][Full Text] [Related]
7. Reduced activation of RAF-1 and MAP kinase by a fibroblast growth factor receptor mutant deficient in stimulation of phosphatidylinositol hydrolysis.
Huang J; Mohammadi M; Rodrigues GA; Schlessinger J
J Biol Chem; 1995 Mar; 270(10):5065-72. PubMed ID: 7534287
[TBL] [Abstract][Full Text] [Related]
8. Control of fibroblast growth factor receptor kinase signal transduction by heterodimerization of combinatorial splice variants.
Shi E; Kan M; Xu J; Wang F; Hou J; McKeehan WL
Mol Cell Biol; 1993 Jul; 13(7):3907-18. PubMed ID: 8321198
[TBL] [Abstract][Full Text] [Related]
9. aFGF binding to low and high affinity receptors induces both aFGF and aFGF receptors dimerization.
Mascarelli F; Fuhrmann G; Courtois Y
Growth Factors; 1993; 8(3):211-33. PubMed ID: 7686384
[TBL] [Abstract][Full Text] [Related]
10. Different tyrosine autophosphorylation requirements in fibroblast growth factor receptor-1 mediate urokinase-type plasminogen activator induction and mitogenesis.
Dell'Era P; Mohammadi M; Presta M
Mol Biol Cell; 1999 Jan; 10(1):23-33. PubMed ID: 9880324
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor receptor-1 mediates chemotaxis independently of direct SH2-domain protein binding.
Landgren E; Klint P; Yokote K; Claesson-Welsh L
Oncogene; 1998 Jul; 17(3):283-91. PubMed ID: 9690510
[TBL] [Abstract][Full Text] [Related]
12. Identification of residues important both for primary receptor binding and specificity in fibroblast growth factor-7.
Sher I; Lang T; Lubinsky-Mink S; Kuhn J; Adir N; Chatterjee S; Schomburg D; Ron D
J Biol Chem; 2000 Nov; 275(45):34881-6. PubMed ID: 10950949
[TBL] [Abstract][Full Text] [Related]
13. A novel type I fibroblast growth factor receptor activates mitogenic signaling in the absence of detectable tyrosine phosphorylation of FRS2.
Lopez ME; Korc M
J Biol Chem; 2000 May; 275(21):15933-9. PubMed ID: 10748122
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine 769 of the keratinocyte growth factor receptor is required for receptor signaling but not endocytosis.
Ceridono M; Belleudi F; Ceccarelli S; Torrisi MR
Biochem Biophys Res Commun; 2005 Feb; 327(2):523-32. PubMed ID: 15629145
[TBL] [Abstract][Full Text] [Related]
15. Identification of tyrosines 154 and 307 in the extracellular domain and 653 and 766 in the intracellular domain as phosphorylation sites in the heparin-binding fibroblast growth factor receptor tyrosine kinase (flg).
Hou J; McKeehan K; Kan M; Carr SA; Huddleston MJ; Crabb JW; McKeehan WL
Protein Sci; 1993 Jan; 2(1):86-92. PubMed ID: 8443592
[TBL] [Abstract][Full Text] [Related]
16. Long term growth factor exposure and differential tyrosine phosphorylation are required for DNA synthesis in BALB/c 3T3 cells.
Zhan X; Hu X; Friesel R; Maciag T
J Biol Chem; 1993 May; 268(13):9611-20. PubMed ID: 7683656
[TBL] [Abstract][Full Text] [Related]
17. Analysis of putative heparin-binding domains of fibroblast growth factor-1. Using site-directed mutagenesis and peptide analogues.
Wong P; Hampton B; Szylobryt E; Gallagher AM; Jaye M; Burgess WH
J Biol Chem; 1995 Oct; 270(43):25805-11. PubMed ID: 7592764
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of functionally different interactions between phospholipase C-gamma and the two types of platelet-derived growth factor receptors.
Eriksson A; Nånberg E; Rönnstrand L; Engström U; Hellman U; Rupp E; Carpenter G; Heldin CH; Claesson-Welsh L
J Biol Chem; 1995 Mar; 270(13):7773-81. PubMed ID: 7535778
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the conserved acidic amino acid domain of FGF receptor 1 in ligand-receptor interaction.
Chaudhuri MM; Moscatelli D; Basilico C
J Cell Physiol; 1993 Nov; 157(2):209-16. PubMed ID: 8227155
[TBL] [Abstract][Full Text] [Related]
20. Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex.
Venkataraman G; Raman R; Sasisekharan V; Sasisekharan R
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3658-63. PubMed ID: 10097093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
